Naproxen (Aleve, Naprosyn) is a non-selective NSAID available both OTC and by prescription, used to treat pain, inflammation, and fever from arthritis, gout, tendinitis, dysmenorrhea, and acute musculoskeletal injury. It works by non-selectively inhibiting COX-1 and COX-2 enzymes, blocking prostaglandin synthesis. Common side effects include GI upset, heartburn, fluid retention, and elevated blood pressure. It carries boxed warnings for serious cardiovascular events and potentially fatal GI bleeding; its 12–17 hour half-life allows twice-daily dosing, and it is contraindicated from 30 weeks of pregnancy onward due to risk of premature closure of the ductus arteriosus.
Naproxen
Uses & FDA Indications
Naproxen is one of the most widely used non-steroidal anti-inflammatory drugs (NSAIDs), available both by prescription (Naprosyn, Anaprox) and over the counter (Aleve). Its relatively long half-life compared to ibuprofen allows for less frequent dosing — a practical advantage for long-term inflammatory conditions.
Prescription naproxen is FDA-approved for the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, and dysmenorrhea (primary menstrual pain). OTC naproxen sodium (Aleve) is approved for the temporary relief of minor pain and fever in adults and children 12 years and older. Because of its long half-life, naproxen is often cited as having a more favorable cardiovascular risk profile among NSAIDs, though all NSAIDs carry some cardiovascular risk.
- Rheumatoid arthritis and osteoarthritis
- Ankylosing spondylitis
- Juvenile idiopathic arthritis (JIA)
- Acute gout
- Tendinitis and bursitis
- Primary dysmenorrhea (menstrual cramps)
- Mild-to-moderate pain (acute musculoskeletal injury, headache, dental pain)
- Fever reduction
How It Works
Like all traditional NSAIDs, naproxen works by non-selectively inhibiting both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes. These enzymes catalyze the conversion of arachidonic acid to prostaglandins — lipid signaling molecules that mediate pain sensitization, inflammation, and fever. By blocking prostaglandin synthesis, naproxen reduces the prostaglandin-mediated sensitization of pain receptors (peripheral sensitization) and the hypothalamic temperature set-point elevation that drives fever.
COX-1 inhibition also reduces production of thromboxane A2 in platelets, impairing platelet aggregation (clotting function) — which contributes to naproxen's GI bleeding risk. Inhibition of prostaglandins in the gastric mucosa reduces the protective mucous layer, increasing vulnerability to ulceration. COX-2 inhibition in the vasculature reduces prostacyclin, a vasodilator and platelet inhibitor — this imbalance toward thromboxane may contribute to cardiovascular risk seen with NSAIDs.
Naproxen's longer half-life (~12–17 hours) means twice-daily or even once-daily dosing is sufficient for chronic conditions — a practical advantage over shorter-acting NSAIDs like ibuprofen. However, the extended duration also means adverse effects persist longer if they occur.
Side Effects
Common
- Gastrointestinal: nausea, dyspepsia, abdominal pain, diarrhea, constipation — most common
- Heartburn and acid reflux
- Headache and dizziness
- Drowsiness
- Tinnitus (ringing in ears) — sign of possible toxicity at high exposures
- Fluid retention and edema
- Elevated blood pressure
Serious
- GI ulceration, perforation, and bleeding — life-threatening; may occur without warning symptoms (Boxed Warning)
- Cardiovascular events — increased risk of myocardial infarction and stroke; risk increases with higher exposures and pre-existing cardiovascular disease (Boxed Warning)
- Acute kidney injury — particularly in patients with volume depletion, heart failure, or baseline renal impairment
- Severe skin reactions — Stevens-Johnson syndrome, toxic epidermal necrolysis, exfoliative dermatitis (rare)
- Liver injury — rare elevation in transaminases; fulminant hepatitis reported rarely
- Anaphylactic reactions — particularly in aspirin-sensitive patients
- Fetal harm — fetal renal dysfunction and oligohydramnios (20–30 weeks); premature closure of ductus arteriosus (30+ weeks)
Drug Interactions
| Drug / Class | Interaction | Clinical Significance |
|---|---|---|
| Aspirin | Naproxen can interfere with aspirin's irreversible platelet inhibition if taken before low-dose aspirin; may blunt cardioprotective effect. Combined use also increases GI bleeding risk | High — if aspirin is needed for cardioprotection, take aspirin 30 min before naproxen |
| Anticoagulants (warfarin, apixaban, rivaroxaban) | NSAIDs impair platelet function and may cause GI mucosal injury; additive bleeding risk with anticoagulants | High — avoid combination; use acetaminophen for analgesia if anticoagulated |
| ACE inhibitors and ARBs | NSAIDs blunt antihypertensive effect; combined use increases risk of acute kidney injury, especially in volume-depleted patients (the "triple whammy" with diuretics) | High — monitor blood pressure and renal function; minimize NSAID use |
| Diuretics (loop and thiazide) | NSAIDs reduce renal prostaglandins, blunting the diuretic effect; risk of fluid retention and worsening heart failure or hypertension | Moderate — monitor blood pressure, weight, and renal function |
| Lithium | NSAIDs reduce renal lithium clearance, increasing lithium levels and toxicity risk | High — monitor lithium levels when starting, stopping, or changing NSAID use |
| Methotrexate | NSAIDs reduce renal methotrexate clearance; risk of methotrexate toxicity (myelosuppression, mucositis) | High — avoid combination or monitor closely in high-dose methotrexate regimens |
| SSRIs / SNRIs | Both impair platelet function; combined use significantly increases GI bleeding risk | Moderate — consider gastroprotection (PPI) if combination is necessary |
Warnings & Contraindications
⚠ BOXED WARNING: NSAIDs including naproxen increase the risk of serious cardiovascular thrombotic events (heart attack, stroke) — risk may increase with duration and higher exposure. ⚠ NSAIDs increase the risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines — which can be fatal. ⚠ Contraindicated for perioperative pain in the setting of coronary artery bypass graft (CABG) surgery.
- Contraindicated: History of asthma, urticaria, or allergic reactions to aspirin or NSAIDs (cross-reactivity); perioperative CABG use; pregnancy at 30 weeks gestation or later; severe heart failure
- GI protection: High-risk patients (age 65+, history of peptic ulcer, concurrent corticosteroid or anticoagulant use) should use a proton pump inhibitor concomitantly
- Renal: Avoid in severe renal impairment; monitor kidney function in patients with pre-existing renal disease, heart failure, or dehydration
- Cardiovascular: Use the lowest effective amount for the shortest duration; avoid in patients with recent MI or stroke; naproxen may have a relatively more favorable CV profile among NSAIDs but risk is not zero
- Aspirin-exacerbated respiratory disease (AERD): Patients with the triad of asthma, nasal polyps, and aspirin sensitivity may experience severe bronchospasm — this is a contraindication
Frequently Asked Questions
Is naproxen safer for the heart than ibuprofen?
Observational studies and network meta-analyses suggest naproxen may have a more favorable cardiovascular risk profile compared to other NSAIDs — possibly because its longer half-life provides more sustained platelet inhibition, partially mimicking aspirin's effect. The PRECISION trial compared celecoxib, naproxen, and ibuprofen and found broadly similar cardiovascular risk profiles among patients with established cardiovascular disease. All NSAIDs carry some cardiovascular risk, and the safest approach is using the lowest effective amount for the shortest duration, regardless of which NSAID is chosen.
Can I take naproxen with ibuprofen?
No — combining two NSAIDs does not provide additional benefit and significantly increases the risk of serious gastrointestinal side effects including ulceration and bleeding. Both drugs inhibit the same enzymes (COX-1 and COX-2), so combining them is mechanistically redundant. If one NSAID is not providing adequate relief, the better approach is to discuss alternatives or combination strategies (e.g., adding acetaminophen) with a healthcare provider.
Why is naproxen sold over the counter as Aleve if it has serious risks?
OTC availability reflects a benefit-risk assessment by the FDA, recognizing that when used at the approved OTC amounts for short durations by otherwise healthy adults, the benefits generally outweigh the risks. The OTC labeling specifies the lowest effective amount for the shortest time needed. The prescription formulations are for higher amounts and conditions requiring medical supervision. Serious NSAID complications are more likely with higher exposures, prolonged use, and in high-risk populations — situations where prescription oversight is appropriate.
Is naproxen safe during pregnancy?
Naproxen should generally be avoided during pregnancy. In the second half of pregnancy (from 20 weeks onward), NSAIDs can cause fetal kidney problems that lead to low amniotic fluid (oligohydramnios). After 30 weeks of gestation, they are contraindicated because they can cause premature closure of the ductus arteriosus — a fetal blood vessel that must remain open until birth. Acetaminophen (paracetamol) is generally considered the preferred analgesic during pregnancy when medication is needed.
Not sure which pill you have? Identify it by imprint, color, or shape.
Use the PillID Identifier →